STENOCARE – First day of trading on NASDAQ FIRST NORTH GROWTH MARKET DENMARK will be 18 May 2020
STENOCARE signs agreement with new prominent supplier, PANAXIA and announces imminent product approval application filing
STENOCARE: Notification of changes in major shareholding and increased holding of own shares.
STENOCARE and OWC Pharmaceutical Research Corp. to enter partnership to develop advanced medical cannabis products
STENOCARE to establish the world’s first hybrid, in-door cultivation facility for production of premium medical cannabis at scale
STENOCARE receives new information from CannTrust that causes immediate quarantine on sales of products from current inventory
STENOCARE products are being used in clinical trials at Rigshospitalet Multiple Sclerosis Center
STENOCARE A/S on track with the planned offering of Medical Cannabis Capsules to offer Danish patients more choice in their treatment